Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colestimide for intractable chronic diarrhea (IBS-D or functional diarrhea)
jRCTs031180044Completed
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of colestilan in Diarrhea-predominant irritable bowel syndrome (IBS-D) and functional diarrhea. Primary endpoint: Change in stool frequency. Started Jan 2019; status: completed.
02
Drugs
colestilan
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)functional diarrhea
Beyond the preview
Go deeper on jRCTs031180044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180044.